Worried about your symptoms?
Start the Currently on Antidepressants test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Try one of these related symptoms.
Insomnia
Nausea
Dry mouth
Weight gain
Stomach ache
Sexual dysfunction
Feeling nauseous
Unexplained weight loss
Rapid weight loss
Low libido
Thirsty all the time
Feeling nauseous all the time but not throwing up
Taking a medication.
Generally, Currently on antidepressants can be related to:
A disorder marked by extreme and persistent shifts in mood that last for weeks to months, from periods of sustained depression to periods of elevated mood and euphoria. The precise cause is unclear, but genetic and environmental factors contribute.
Osteoporosis is a disease that makes your bones weak and brittle. As result, the bones become more prone to break even with minor trauma or stress that would normally not result in a break. It may be caused due to long-term low calcium intake, estrogen deficiencies in women, and an inactive lifestyle.
Your doctor may ask these questions to check for this symptom:
Reviewed By:
Charles Carlson, DO, MS (Psychiatry)
Dr. Carlson graduated from Touro University in Nevada with a degree in osteopathic medicine. He then trained as a resident in Psychiatry at Case Western Reserve University/University Hospitals where he was also a chief resident and completed a fellowship in Public and Community Psychiatry. After training, he started practicing in | Addiction Psychiatry at the U.S. Department of Veterans Affairs where he also teaches Psychiatry residents.
Yu Shirai, MD (Psychiatry)
Dr. Shirai works at the Yotsuya Yui Clinic for mental health treatment for English and Portuguese-speaking patients. He treats a wide range of patients from neurodevelopmental disorders to dementia in children and participates in knowledge sharing through the Diversity Clinic.
Content updated on Jan 29, 2025
Following the Medical Content Editorial Policy
Was this page helpful?
We would love to help them too.
With a free 3-min Currently on Antidepressants quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms

Our AI

Your report

Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
Q.
Is Genetic Testing for Antidepressants Worth the Cost? Why Your DNA Is Rejecting Your Meds
A.
There are several factors to consider. Genetic testing can be worth the cost mainly if you have tried multiple antidepressants or had severe side effects, since evidence shows it may modestly reduce trial and error, but it is not a guarantee and is usually unnecessary for a first or successful trial. Tests often cost 100 to 500 dollars and may be partly covered; results center on genes like CYP2D6 and CYP2C19 that can make a drug too strong or too weak, which is why meds can feel “rejected.” For who should test, how to use results with your doctor, cost details, and urgent safety signs, see below.
References:
* Bredemeier M, Kappel L, Bücker J, Treml J, Steinacher B, Lenger K, Gündert F, Stange L, Zangl N, Bumb JM, Nieratschker V, Kirschbaum T. Cost-effectiveness of pharmacogenomic testing in the treatment of major depressive disorder: a systematic review. J Affect Disord. 2023 Feb 1;322:316-326. doi: 10.1016/j.jad.2022.11.002. Epub 2022 Nov 25. PMID: 36551897.
* Kato M, Lenze EJ, Mrazek DA, Tamminga CA, Alshehri B, Agrawal S, Kaddoura T, Taylor WD, Zorumski CF, Miller JP. Clinical Utility of Pharmacogenomic-Guided Antidepressant Prescribing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Psychiatry. 2022 Oct 18;83(6):21r14332. doi: 10.4088/JCP.21r14332. PMID: 36254778.
* Cai D, Yu F, Song Y, Zhu C, Xie W, Wang Y, Xu C. Pharmacogenomic testing for antidepressant treatment: a review of the evidence and practical implications. Ann Transl Med. 2022 Jul;10(13):753. doi: 10.21037/atm-2022-10. Epub 2022 Jul 16. PMID: 35928813.
* Kohli S, Leng T, Shah P, Sikka M, Ngufor C, Thach A, Jancic N, Alshehri B, Kaddoura T, Miller JP. Pharmacogenomic Testing for Treatment of Depression: A Systematic Review and Meta-Analysis. J Clin Psychiatry. 2021 May 11;82(3):20r13653. doi: 10.4088/JCP.20r13653. PMID: 33829051.
* Hicks JK, Swen JJ, Müller DJ. The Role of CYP2D6 and CYP2C19 in Antidepressant Drug Metabolism and Clinical Response. Clin Pharmacol Ther. 2019 Aug;106(2):271-274. doi: 10.1002/cpt.1491. Epub 2019 Jul 23. PMID: 31333118.
Q.
Meds Failing? Why Your Brain is Resisting & New Medical Next Steps
A.
If your antidepressants seem to stop working, there are several factors to consider; see below to understand more. Causes can include brain adaptation (tachyphylaxis), a suboptimal dose or medication match, rising stress, missed doses, or an underlying condition, and key warning signs are the return of symptoms, emotional numbness, increased anxiety, or new suicidal thoughts. Next steps usually mean reassessing with your clinician to adjust the dose, switch or add medications, pair with therapy, check labs and medical contributors, and consider newer options when needed; urgent care is needed for suicidal thoughts or severe symptoms, and full details plus talking points for your appointment are below.
References:
* Raison CL, et al. The neurobiology of treatment-resistant depression: focus on inflammation and glutamatergic dysfunction. Mol Psychiatry. 2022 Mar;27(3):1414-1426. doi: 10.1038/s41380-022-01452-9. Epub 2022 Feb 22. PMID: 35190623; PMCID: PMC8919688.
* Jelen LA, et al. Treatment Resistance in Psychiatric Disorders: Biological and Clinical Perspectives. JAMA Psychiatry. 2021 Mar 1;78(3):328-338. doi: 10.1001/jamapsychiatry.2020.3541. PMID: 33175111; PMCID: PMC7661649.
* Machado-Vieira R, et al. Novel therapeutic approaches for treatment-resistant depression. Int J Mol Sci. 2022 May 11;23(10):5364. doi: 10.3390/ijms23105364. PMID: 35628178; PMCID: PMC9140416.
* Löscher W, et al. Treatment resistance in epilepsy: Mechanisms and therapeutic strategies. Neuropharmacology. 2021 Oct;197:108740. doi: 10.1016/j.neuropharm.2021.108740. Epub 2021 Jun 22. PMID: 34166723.
* Kautzky A, et al. Precision medicine for treatment resistant depression: A systematic review of biomarker studies. J Psychiatr Res. 2022 Apr;149:381-396. doi: 10.1016/j.jpsychires.2022.03.012. Epub 2022 Mar 15. PMID: 35303530.
Q.
Meds Not Working? Why Your Brain is Resistant & New TMS Therapy Steps
A.
There are several factors to consider; many people do not fully improve on antidepressants because depression often involves brain circuit dysfunction, genetics, inflammation, stress systems, and sleep issues, leading to treatment-resistant depression. TMS is an FDA-cleared, noninvasive option that directly targets these underactive mood circuits and can help when meds fail, and the steps for candidacy, the typical 4 to 6 week course, safety, insurance, and urgent signs to act on are explained below.
References:
* Alpert, J. E., & Fava, M. (2018). Neurobiology and Treatment of Treatment-Resistant Depression. *Primary Care Companion for CNS Disorders*, *20*(4).
* Ma, Z., Wu, M., Lu, S., & Wang, X. (2020). Transcranial magnetic stimulation for treatment-resistant depression: An update. *Frontiers in Psychiatry*, *11*, 763.
* Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Wittenberg, L., Tischler, R., ... & Etkin, A. (2020). Accelerated repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression: a systematic review and meta-analysis. *Biological Psychiatry*, *87*(11), 1024–1034.
* Frodl, T., & O'Leary, E. (2017). Neurobiology of treatment-resistant depression: an integrated approach. *Dialogues in Clinical Neuroscience*, *19*(3), 297–306.
* Li, T., Wang, Q., Li, J., Ma, C., Liu, Q., Yang, X., ... & Wei, J. (2021). Predictors and Biomarkers of Response to Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression: A Narrative Review. *Frontiers in Psychiatry*, *12*, 767851.
Q.
Ready to Quit SSRIs? Why Your Brain Is Reacting and New Medical Next Steps
A.
SSRIs change how your brain handles serotonin, so stopping suddenly can trigger discontinuation symptoms like dizziness, brain zaps, and anxiety that can be hard to tell apart from true relapse. If long-term side effects such as sexual problems, emotional blunting, weight gain, sleep changes, or cognitive fog are pushing you to stop, a slow, doctor-guided taper is usually the safest path. There are several factors to consider, including taper timing, bridging to longer-acting meds, therapy and lifestyle supports, how to monitor for relapse, and urgent red flags that need immediate care; see below for the complete, step-by-step medical next steps to discuss with your clinician.
References:
* Fava GA, Gatti C, Giusti L, et al. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Narrative Review. Ann Pharmacother. 2021 Jul;55(7):922-936. doi: 10.1177/1060028020970094. Epub 2020 Nov 2. PMID: 33131346.
* Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav. 2019 May;92:78-87. doi: 10.1016/j.addbeh.2018.11.006. Epub 2018 Dec 20. PMID: 30594639.
* Horowitz MA, Taylor D. Tapering antidepressants. BMJ. 2019 May 15;365:l2426. doi: 10.1136/bmj.l2426. PMID: 31092592.
* El-Mallakh RS, Waring SM, Ebright L, et al. Discontinuation syndrome in antidepressant use: a review of the pathophysiology and clinical features. Clin Psychopharmacol Neurosci. 2023 Nov 30;21(4):689-700. doi: 10.9758/cpn.2023.21.4.689. PMID: 38043694.
* Read J, Davies J. What are the best ways to stop antidepressants? A narrative review of the evidence for clinicians and patients. Ther Adv Psychopharmacol. 2022 Mar 15;12:20451253221085023. doi: 10.1177/20451253221085023. PMID: 35310636.
Q.
Is Generic Zoloft Different? Why Sertraline Varies & Medical Next Steps
A.
Generic Zoloft sertraline is medically equivalent to the brand and meets strict FDA bioequivalence standards, but differences in inactive ingredients and manufacturer switches can make some people feel different. There are several factors to consider; see below to understand more. If you notice changes, do not stop abruptly and instead track symptoms, ask your pharmacist to keep the same generic manufacturer, and talk with your clinician about dose adjustments or trying brand when fillers are an issue, while seeking urgent care for any severe or safety concerns.
References:
* Kumar A, Singh SK, Shrivastav P, Kaur G. Bioequivalence Study of Two Formulations of Sertraline Tablets (50 mg) in Healthy Volunteers Under Fasting Conditions. Indian J Pharm Sci. 2011 Nov;73(6):715-9. doi: 10.4103/0250-474X.106069. PMID: 23372233; PMCID: PMC3569724.
* Pampaloni A, Balestrieri M, Fabbri C. Therapeutic equivalence of generic and innovator psychotropic drugs: A systematic review and meta-analysis. Expert Opin Drug Saf. 2018 Jun;17(6):575-585. doi: 10.1080/14740338.2018.1472859. Epub 2018 May 16. PMID: 29737877.
* Patel R, Baras Sh. Challenges in switching between generic and brand-name antidepressant medications: A review of evidence. J Clin Psychopharmacol. 2013 Aug;33(4):514-23. doi: 10.1097/JCP.0b013e31829e577d. PMID: 23838660.
* Davidoff F, et al. Variability in Generic Drug Products and the Potential Impact on Therapeutic Outcomes. Clin Ther. 2016 Jun;38(6):1314-23. doi: 10.1016/j.clinthera.2016.05.006. Epub 2016 Jun 1. PMID: 27263901.
* Shapiro P, Baras Sh. Patient Experience With Generic Antidepressant Substitutions: A Scoping Review. J Clin Psychopharmacol. 2021 Jul-Aug;41(4):450-459. doi: 10.1097/JCP.0000000000001402. PMID: 34091461.
Q.
Vilazodone Side Effects? Why Your Brain Is Reacting & Medically Approved Next Steps
A.
Vilazodone often causes early side effects like nausea, diarrhea, stomach upset, headache, dizziness, insomnia or vivid dreams, and sexual changes as your brain and gut adjust to higher serotonin, and many of these improve over 1 to 2 weeks. There are several factors to consider; medically approved next steps include taking each dose with food, not stopping suddenly, tracking symptoms and interactions with other medicines, discussing dose adjustments with your doctor, and seeking urgent care for red flags like suicidal thoughts, severe agitation, high fever, muscle stiffness, confusion, chest pain, or signs of serotonin syndrome. See the complete guidance below to understand more and choose the safest next steps.
References:
* Sheehan, D. V., & Gommoll, C. P. (2015). A comprehensive review of the efficacy and safety of vilazodone in the treatment of major depressive disorder. *Therapeutic Advances in Psychopharmacology*, *5*(1), 16-30.
* Lader, M., & Gommoll, C. P. (2016). Clinical pharmacology of vilazodone. *Journal of Clinical Psychopharmacology*, *36*(3), 205-212.
* Khan, A., Fava, M., & Finkelman, M. (2014). Efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a meta-analysis. *Journal of Affective Disorders*, *166*, 151-158.
* Stahl, S. M. (2018). The role of 5-HT1A agonism in antidepressant action: a review of vilazodone. *CNS Spectrums*, *23*(3), 209-216.
* Gommoll, C. P., et al. (2012). Pooled analysis of the tolerability and safety of vilazodone in patients with major depressive disorder. *International Clinical Psychopharmacology*, *27*(5), 260-267.
Q.
Celexa Side Effects? Why Your Brain Reacts & Medically Approved Next Steps
A.
Celexa (citalopram) boosts serotonin in the brain and gut, so early digestive changes, sleep issues, headaches, sweating, and sexual side effects are common and usually improve within 2 to 4 weeks, while rare but serious risks include worsening mood or suicidality, heart rhythm problems from QT prolongation, and serotonin syndrome; stopping suddenly can trigger discontinuation symptoms. There are several factors to consider; see below for who is at higher risk and what to watch for, plus medically approved next steps like tracking symptoms, giving it time if mild, discussing dose changes or switching, adding therapy and lifestyle supports, tapering rather than stopping, and when to seek urgent care.
References:
* Montejo AL, Llorca G, Izquierdo J, Ledesma A. Adverse effects of the newer antidepressants. J Clin Psychiatry. 2016 Sep;77(9):e1124-34. doi: 10.4088/JCP.14ac09653. PMID: 27685044.
* Waldinger MD, Schweitzer DH. Mechanisms of serotonin reuptake inhibitor-induced sexual dysfunction. Curr Top Behav Neurosci. 2015;21:409-26. doi: 10.1007/7858_2013_357. PMID: 24203770.
* Cartwright C, et al. Antidepressant adverse drug reactions: The view from the patient. Hum Psychopharmacol. 2020 Jul;35(4):e2730. doi: 10.1002/hup.2730. Epub 2020 May 25. PMID: 32452030.
* Chouinard G, Chouinard V-A. Antidepressant discontinuation syndrome: when and how to identify and manage it. J Clin Psychopharmacol. 2015 Oct;35(5 Suppl 1):S18-23. doi: 10.1097/JCP.0000000000000392. PMID: 26366113.
* Rush AJ, Trivedi MH, Fava M. Managing Antidepressant Side Effects. Am J Psychiatry. 2020 Aug 1;177(8):723-725. doi: 10.1176/appi.ajp.2020.20050596. PMID: 32731872.
Q.
Tired of Symptoms? Cyproheptadine and Your Medically Approved Next Steps
A.
Cyproheptadine can help with allergies, migraine prevention, appetite loss, and even serotonin syndrome by blocking histamine and serotonin, but it must be used under medical guidance due to sedation and other risks. There are several factors to consider, including interactions with antidepressants, who should avoid it, and the right medically approved next steps like symptom tracking, med review, and when to seek urgent care. See below to understand more.
References:
* Srinivasan, R., & Jain, S. (2020). Cyproheptadine: A Review of the Clinical Indications, Pharmacokinetics, and Adverse Effects. *Current Drug Discovery, 17*(4), 589-598.
* Chacko, M. P., & O'Toole, L. P. (2020). Cyproheptadine as an appetite stimulant: a narrative review. *Journal of Pediatric Pharmacology and Therapeutics, 25*(4), 312-321.
* Balasubramanian, S., Agarwal, A., & Anand, V. (2022). Cyproheptadine and the serotonin syndrome: A systematic review of cases. *Journal of Clinical Psychopharmacology, 42*(5), 452-458.
* Slavova, I., Nagesh, K. N., & O'Halloran, P. J. (2018). Cyproheptadine in the Management of Post-Traumatic Headache in Children and Adolescents. *Headache: The Journal of Head and Face Pain, 58*(1), 164-167.
* Eikenboom, S. L., Di Lorenzo, C., & Hyman, P. E. (2021). Cyproheptadine for the treatment of cyclic vomiting syndrome: a comprehensive review. *Pediatric Drugs, 23*(5), 473-481.
Q.
Zoloft Side Effects? Why You Feel Worse & Medically Approved Next Steps
A.
It is common to feel temporarily worse on Zoloft, with nausea, sleep changes, and increased anxiety often appearing in the first days and easing within 1 to 3 weeks as your brain adapts, while full mood benefits can take 4 to 8 weeks. Seek urgent care for suicidal thoughts, severe agitation, allergic reactions, or signs of serotonin syndrome, and talk to your doctor if side effects are intense or persist so you can adjust dose or timing rather than stopping suddenly. There are several factors to consider, including practical ways to manage side effects, who is at higher risk, and what changes to discuss with your clinician, so see the complete guidance below.
References:
* Lee, K. C., Lu, C. Y., & Wu, P. C. (2023). Sertraline: an updated review of its use in mental health. *Expert Opinion on Drug Metabolism & Toxicology*, *19*(9), 565-578.
* Rizzato, S., & Biffi, A. (2017). Safety and Tolerability of Serotonin Reuptake Inhibitors: A Systematic Review. *Psychiatric Quarterly*, *88*(3), 567-582.
* Garay, A., Marini, M., Di Landro, C., Perna, G., & Daccò, S. (2021). Paradoxical Anxiety in Patients Treated With Antidepressants: Diagnosis, Clinical Implications, and Treatment. *Frontiers in Psychiatry*, *12*, 697921.
* Heng, S. L., Cheang, H. H., Lai, Y. H., & Ng, C. G. (2022). Identifying and managing antidepressant discontinuation symptoms. *Journal of Clinical Pharmacy and Therapeutics*, *47*(10), 1622-1629.
* Rush, A. J., & Fava, M. (2016). Managing the adverse effects of pharmacotherapy for depression. *F1000Research*, *5*, F1000 Faculty Rev-571.
Q.
Lexapro Side Effects? Why Your Body Reacts & Medical Next Steps
A.
Lexapro commonly causes temporary nausea, headache, GI or sleep changes, sweating, dizziness, fatigue, and a brief spike in anxiety during the first 1 to 2 weeks as your serotonin system adjusts, with most effects easing by 2 to 4 weeks. There are several factors to consider, including rare but serious problems like serotonin syndrome, suicidal thoughts in people under 25, low sodium, and heart rhythm changes that need urgent care, and sexual side effects that may persist; do not stop suddenly, and speak with your doctor if symptoms are severe or lasting or if you see no improvement after 6 to 8 weeks. See the complete details and medical next steps below.
References:
* Gupta S, Gupta M, Marwaha P, et al. Adverse effects of antidepressants. *Handb Clin Neurol*. 2021;182:313-329.
* Volkov I, Druss BG, Adair K, et al. Mechanisms and management of adverse effects of psychiatric medications. *Curr Treat Options Psychiatry*. 2014 Dec;1(4):301-314.
* Wong C, Al-Hajri R, Tandon S, et al. Pharmacological treatment of antidepressant-induced sexual dysfunction. *Expert Opin Pharmacother*. 2022 May;23(7):789-804.
* Haddad P. Antidepressant discontinuation syndrome: a clinical review. *Postgrad Med*. 2012 Jul;124(4):7-17.
* Owens MJ, Nemeroff CB. Escitalopram: a review of its use in the management of major depressive disorder. *Drugs*. 2008;68(14):1955-76.
Q.
Sertraline Side Effects? The Science & Medically Approved Next Steps
A.
Sertraline side effects are usually mild and short lived nausea, diarrhea, sleep or sexual changes, headache, dizziness, and early anxiety. Rare but serious issues like serotonin syndrome, suicidal thoughts in younger people, severe allergy, unusual bleeding, or low sodium need urgent care. There are several factors to consider, including timing, dose and interactions, and you should not stop suddenly; see the medically approved next steps below to decide when to monitor, adjust treatment with your doctor, or seek emergency help.
References:
* Zhou, J., Li, Y., Wang, X., Zeng, D., Xiao, W., & Li, C. (2021). Adverse effects of sertraline: A systematic review and meta-analysis of randomized controlled trials. *Expert Opinion on Drug Safety*, *20*(4), 481-492. PMID: 33502859.
* Waldinger, M. D., & Schweitzer, D. H. (2018). Sexual side effects of selective serotonin reuptake inhibitors: a comprehensive review. *Psychiatric Clinics of North America*, *41*(2), 295-305. PMID: 29705986.
* Fava, G. A., Gatti, A., Gatti, F., & Fava, M. (2018). Antidepressant discontinuation syndrome: a systematic review. *Psychotherapy and Psychosomatics*, *87*(3), 119-127. PMID: 29742686.
* Polcwiartek, C., Vinding, H. R., & Nielsen, C. (2017). Adverse effects of antidepressants in children and adolescents: a review of the literature. *Pediatric Drugs*, *19*(3), 207-221. PMID: 28357876.
* Cini, A., & Salvi, V. (2018). Sertraline: a review of its use in clinical practice. *Drugs in Context*, *7*, 212519. PMID: 30429718.
Q.
Sertraline Side Effects? Why Your Body Reacts & Medically Approved Steps
A.
Sertraline can cause short term nausea, stomach upset, sleep changes, headaches, increased sweating, and sexual side effects as your body adapts to serotonin, while rarer problems like serotonin syndrome, unusual bleeding, low sodium, or new suicidal thoughts require urgent care; approved steps include giving it 2 to 4 weeks, adjusting dose or timing with your doctor, checking for interactions, and never stopping suddenly. There are several factors to consider that can change your next steps, such as age, other medicines, and starting dose; see below for detailed symptoms to watch for, what helps, and exactly when to contact a clinician.
References:
* Al-Hussainy, K. Y., Alzoubi, K. H., Al-Azzam, S. I., & Alshogran, O. Y. (2021). Sertraline-Induced Adverse Drug Reactions: A Systematic Review. *Frontiers in Pharmacology*, *12*, 666736. doi: 10.3389/fphar.2021.666736
* Stahl, S. M., & Pilon, D. (2016). Managing the Side Effects of Antidepressant Treatment. *Dialogues in Clinical Neuroscience*, *18*(3), 253–256. doi: 10.31887/DCNS.2016.18.3/smstahl
* Stein, D. J., & Ruscio, A. M. (2019). The Efficacy and Tolerability of Sertraline in the Treatment of Anxiety Disorders: A Comprehensive Review. *CNS Spectrums*, *24*(S1), 3–14. doi: 10.1017/S109285291900018X
* Montejo, A. L., Llorca, G., Izquierdo, J. A., & Rico-Villademoros, F. (2015). Antidepressant-induced sexual dysfunction: a review. *Journal of Sex & Marital Therapy*, *41*(1), 1–17. doi: 10.1080/0092623X.2014.908000
* Zink, M., & Henn, F. A. (2012). Pharmacology of sertraline. *Psychopharmacology*, *219*(4), 1011–1020. doi: 10.1007/s00213-011-2553-7
Q.
Still Anxious? How Hydroxyzine Works & Medically Approved Next Steps
A.
Hydroxyzine is an antihistamine that can quickly calm acute anxiety and aid sleep by blocking histamine, typically starting to work within 15 to 30 minutes. Its effect is short lived and it does not treat the underlying biology of chronic anxiety conditions. If you are still anxious, there are several factors to consider including dose adjustments, adding or switching to long term options like SSRIs or SNRIs, starting CBT, targeted lifestyle changes, and safety issues like QT related heart rhythm risk and when to seek urgent care; see the complete, step by step guidance below.
References:
* Lader M, Scotto di Tella E. Hydroxyzine for generalized anxiety disorder: an update. Expert Opin Pharmacother. 2013 Aug;14(12):1705-13. doi: 10.1517/14656566.2013.805541. Epub 2013 Jun 25. PMID: 23790101.
* Cao Y, Wang Y, Xu C, Sun X, Su B, Wu G. The efficacy and safety of hydroxyzine in the treatment of anxiety disorders: A systematic review and meta-analysis. Medicine (Baltimore). 2021 May 28;100(21):e25860. doi: 10.1097/MD.0000000000025860. PMID: 34043743; PMCID: PMC8168249.
* Bandelow B, Michaelis S, Wedekind D. Management of generalized anxiety disorder. Curr Opin Psychiatry. 2017 Jan;30(1):56-62. doi: 10.1097/YCO.0000000000000300. PMID: 27926510.
* Craske MG, Rauch SA, Cahill SP, Vrshek-Schallhorn S, Holmes EA, King MW, Pine DS, Tolin DF, Yip AG. Cognitive behavioral therapy for anxiety disorders: an update on the evidence base. Depress Anxiety. 2022 Mar 22. doi: 10.1002/da.23236. Epub ahead of print. PMID: 35315147.
* Baldwin DS, Denys D. Recent advances in the pharmacotherapy of generalized anxiety disorder. Neuropsychiatr Dis Treat. 2019 May 22;15:1359-1369. doi: 10.2147/NDT.S184752. eCollection 2019. PMID: 31190772; PMCID: PMC6540449.
Q.
Still Hurting? Why Omeprazole Fails & Medically Approved Next Steps
A.
If omeprazole is not relieving your heartburn or chest and throat discomfort, there are several factors to consider, including incorrect timing or dose, rapid metabolism or a need for a different PPI, non-acid reflux, functional heartburn, H. pylori, gastroparesis, or a non-reflux cause. Medically approved next steps include confirming the true cause with testing, optimizing or switching medications and adding adjuncts, pairing treatment with targeted lifestyle changes, and assessing for structural problems. Urgent red flags and long term safety tips, including not stopping abruptly, are outlined below; see below for details that could change which next steps are right for you.
References:
* DiMarino Jr, A. J., & Semler, J. R. (2020). Refractory gastroesophageal reflux disease: current and future perspectives. *Therapeutic Advances in Gastroenterology, 13*, 1756284820921800.
* Cho, Y. K., & Kim, G. H. (2018). Refractory GERD: what next? *Gut and Liver, 12*(4), 381–383.
* Noh, K., Choi, D., & Kim, M. S. (2020). Mechanisms and Management of Refractory Gastroesophageal Reflux Disease. *Journal of Neurogastroenterology and Motility, 26*(3), 291–300.
* Sifrim, D. (2018). Causes and management of refractory gastroesophageal reflux disease. *Annals of the New York Academy of Sciences, 1434*(1), 263–274.
* Hagymási, K., & Müllner, K. (2018). Current treatment of refractory GERD. *Current Opinion in Pharmacology, 43*, 1–7.
Q.
Feeling Worse on Citalopram? Why Your Brain Is Reacting & Medical Next Steps
A.
Feeling worse after starting citalopram is common in the first 1 to 3 weeks as your brain adjusts, with temporary side effects like increased anxiety, sleep disruption, and restlessness; benefits often become clearer by weeks 3 to 8. There are several factors to consider, including dose, medication interactions, and possible bipolar features. Seek urgent care for red flags such as new or worsening suicidal thoughts, severe agitation, confusion with fever and muscle stiffness, or fainting and heart rhythm changes, and do not stop the medicine suddenly. For practical coping tips, safe dose adjustments with your prescriber, and other key details that could change your next steps, see the full guidance below.
References:
* Biederman J, Mick E, Aleardi M, Wozniak J, Spencer T, Faraone SV. Paradoxical worsening of anxiety with SSRI treatment: a case series. J Clin Psychiatry. 2009 Feb;70(2):290-3. doi: 10.4088/jcp.v70n0221. PMID: 19161245.
* Nutt DJ, Forshall S, Bell CJ, Walsh SM, MacLeod NK. Mechanisms of SSRI-induced anxiety and their implications for the treatment of mood and anxiety disorders. Drug Discov Today. 2014 Jul;19(7):1001-9. doi: 10.1016/j.drudis.2014.03.003. Epub 2014 Apr 3. PMID: 24706509.
* Fabbri C, Marsano A, Di Bella D, Crisafulli C, De Ronchi D, Serretti A. Pharmacogenetics of citalopram and escitalopram: a systematic review of the evidence. Pharmacogenomics J. 2012 Feb;12(1):30-42. doi: 10.1038/tpj.2011.23. Epub 2011 May 10. PMID: 21556012.
* Preskorn SH. Acute Adverse Effects of Antidepressants: Recognition and Management. J Psychiatr Pract. 2018 Mar;24(2):137-142. doi: 10.1097/PRA.0000000000000287. PMID: 29532556.
* Baldwin DS, Bobes J, Emsley R, García-Campayo J, Matthews K, Uhlenhuth EH, Blay S. Strategies for managing antidepressant side effects. CNS Drugs. 2016 Mar;30(3):195-212. doi: 10.1007/s40263-016-0331-z. PMID: 26861614.
Q.
Feeling Worse on Escitalopram? Why Your Brain Is Reacting + Medical Next Steps
A.
Feeling worse after starting escitalopram is common in the first weeks as your brain adjusts to serotonin, causing temporary activation symptoms like anxiety, restlessness, insomnia, nausea, or headaches; sometimes it points to dose issues, bipolar spectrum, or rare risks like increased suicidal thoughts that need urgent care. There are several factors and timelines to consider, so do not stop suddenly; track symptoms and contact your prescriber for changes or supports, and see below for the full checklist and red flags that could change your next steps today.
References:
* Østergaard SD, Jensen HM, Jørgensen MB. Early worsening of anxiety in major depressive disorder treated with escitalopram: A pooled analysis of acute treatment studies. Eur Neuropsychopharmacol. 2017 Jul;27(7):727-733. doi: 10.1016/j.euroneuro.2017.05.006. Epub 2017 May 30. PMID: 29997973.
* De Montigny C. Early changes in serotonin receptor function in the development of antidepressant effects. J Psychiatry Neurosci. 2004 May;29(3):203-9. PMID: 15159051.
* Maletic V, Ekeocha T, Maletic J, Radin D. Strategies for the management of antidepressant-induced adverse events: a review. Ann Gen Psychiatry. 2021 Mar 17;20(1):16. doi: 10.1186/s12991-021-00336-7. PMID: 33737083.
* Cipriani A, Papola D, Salanti G, Furukawa TA, Amato L, Barretta P, Carnaghi B, Cecchelli C, Chaimani A, Danese A, de Braal D, Demurtas J, Desmedt J, Egger M, Gallo D, Purgato M, Santonastaso M, Trelle S, Takeshima N, Tedeschi F, Watanabe N, Zortea T, Geddes JR. Antidepressant Switching Strategies: A Systematic Review and Network Meta-analysis. J Clin Psychiatry. 2021 Jan 26;82(1):20m13626. doi: 10.4088/JCP.20m13626. PMID: 33502802.
* Singh S, Singh A, Tripathi N, Kumar M, Gupta A, Mishra A, Singh K, Pandey P, Yadav M, Yadav AK. Pharmacogenetics of Escitalopram: A Review. Curr Mol Pharmacol. 2020;13(3):218-228. doi: 10.2174/1874467212666190708115629. PMID: 32629474.
Q.
Is It Brain Fog? Why Your Mind Feels Heavy and Medical Next Steps for Prozac
A.
There are several factors to consider: a heavy, foggy mind can come from Prozac, from depression or anxiety, poor sleep, stress, medical issues, or medication interactions, and timing around starting or changing your dose can be a key clue. Next steps include tracking symptoms, optimizing sleep and hydration, and speaking with your doctor about dose or timing adjustments, lab checks, interaction review, or switching medicines; do not stop Prozac abruptly, and seek urgent care for sudden confusion, neurological symptoms, serotonin warning signs, or suicidal thoughts. See below for important details and red flags that could change what you do next.
References:
* Munkholm K, Kessing LV, Miskowiak KW. The impact of selective serotonin reuptake inhibitors on executive function: A systematic review. Eur Neuropsychopharmacol. 2019 Jan;29(1):117-133. doi: 10.1016/j.euroneuro.2018.10.012. Epub 2018 Nov 5. PMID: 30404746.
* Baune BT, Ruckhäberle E, Kessing LV, Miskowiak KW, Munkholm K. Subjective cognitive decline in mood disorders: A systematic review and meta-analysis. J Affect Disord. 2021 Mar 1;282:1062-1073. doi: 10.1016/j.jad.2020.12.148. Epub 2021 Jan 18. PMID: 33494050.
* McIntyre RS, Best O, Bowie CR, DeGeorge KM, Kan C, Lam RW, Miskowiak KW, Subramaniapillai M. Cognitive dysfunction in major depressive disorder: clinical challenges and therapeutic options. Neuropsychiatr Dis Treat. 2017 Mar 21;13:717-727. doi: 10.2147/NDT.S128325. PMID: 28367098; PMCID: PMC5368307.
* Molendijk ML, Bus B, Spijker AT, de Kloet ER, Penninx BW, Zitman FG. Selective serotonin reuptake inhibitors (SSRIs) and brain-derived neurotrophic factor (BDNF) in major depression: a comprehensive review. Eur Neuropsychopharmacol. 2014 Dec;24(12):1914-25. doi: 10.1016/j.euroneuro.2014.10.009. Epub 2014 Oct 29. PMID: 25441865.
* Papakostas GI. Cognitive function in major depressive disorder and the effect of antidepressant treatment: a review. CNS Spectr. 2014 Jun;19(3):238-48. doi: 10.1017/S109285291400030X. PMID: 24968254.
Q.
Lexapro for Women 30-45: Symptom Guide & Critical Next Steps
A.
For women 30 to 45, Lexapro can help relieve depression and anxiety with benefits building over 4 to 8 weeks, but watch for common effects like sleep or sexual changes, possible weight gain, and emotional blunting, and know urgent red flags that require immediate care such as new suicidal thoughts or signs of serotonin syndrome. There are several factors to consider, including perimenopausal hormones, fertility or pregnancy plans, not stopping suddenly, and next steps like tracking symptoms, early follow-ups, and adding therapy and lifestyle support; see the complete guidance below to choose the safest, most effective plan.
References:
* Shah N, et al. Escitalopram in the treatment of women with major depressive disorder: a systematic review. Expert Opin Pharmacother. 2011 Sep;12(13):2059-69. doi: 10.1517/14656566.2011.602554. PMID: 21919782.
* Yonkers KA, et al. Antidepressant Use in Reproductive-Aged Women: Clinical Considerations. Psychiatr Clin North Am. 2017 Mar;40(1):15-32. doi: 10.1016/j.psc.2016.10.002. PMID: 28153177.
* Keltz D, et al. Sexual Dysfunction in Women Treated With SSRIs: A Review of the Literature. J Clin Psychiatry. 2021 Mar 9;82(2):null. doi: 10.4088/JCP.19r13054. PMID: 33705001.
* Patel S, et al. Weight gain associated with escitalopram: a review of current evidence and clinical considerations. Expert Opin Drug Saf. 2021 Jan;20(1):79-90. doi: 10.1080/14740338.2021.1852934. PMID: 33249969.
* Bunevicius A, et al. Pharmacologic Treatment of Premenstrual Dysphoric Disorder: A Review. J Clin Psychiatry. 2020 Jan 28;81(1):null. doi: 10.4088/JCP.19r12918. PMID: 31995166.
Q.
Venlafaxine for Women 30-45: Side Effects & What to Do Next
A.
For women 30 to 45, venlafaxine can be effective for depression and anxiety, but side effects like nausea, sleep changes, sweating, sexual problems, headaches or dizziness, weight changes, and higher blood pressure can occur, and rare issues like serotonin syndrome or severe mood shifts require urgent care. There are several factors to consider; see below to understand more. Next steps include monitoring blood pressure, not stopping the medication abruptly due to withdrawal, seeking immediate help for red flags such as fever, confusion, chest pain, or suicidal thoughts, and discussing pregnancy or perimenopause with your clinician; complete details and what to do in each situation are outlined below.
References:
* Mei, B., Lin, Y., Wan, D., Li, X., Wu, X., & Liu, Z. (2020). Side effects of venlafaxine in the treatment of major depressive disorder: a systematic review and meta-analysis. European Journal of Clinical Pharmacology, 76(2), 163–175. PMID: 31734614.
* Clayton, A. H., & El Haddad, H. (2016). Management of antidepressant-induced sexual dysfunction. Dialogues in Clinical Neuroscience, 18(2), 159–168. PMID: 27489508.
* Pirotta, A. F., & Manion, J. A. (2022). Antidepressant withdrawal syndrome: a narrative review for the generalist. Australian Journal of General Practice, 51(3), 164–168. PMID: 35246700.
* Althoff, T., Stübner, S., Aicher, K., & Pfeiffer, T. (2022). Antidepressant use in women of reproductive age: A systematic review of the adverse effects. Journal of Psychiatric Research, 151, 10–22. PMID: 35303531.
* Thase, M. E. (2014). The Role of Venlafaxine Extended-Release (XR) in the Treatment of Depression and Other Psychiatric Disorders. Dialogues in Clinical Neuroscience, 16(4), 499–513. PMID: 25567906.
Q.
Trazodone Side Effects in Seniors: What Women 65+ Must Know
A.
For women 65 and older, trazodone can help sleep and mood but aging raises the risk of side effects like morning sedation and dizziness, falls from low blood pressure, heart rhythm changes, cognitive fog, and medication interactions, so doses should start low and be monitored closely. There are several factors to consider, and red flags like fainting, chest pain or palpitations, sudden confusion, severe dizziness, or symptoms of serotonin syndrome need immediate care. See below for complete details and practical next steps to discuss with your clinician.
References:
* Jager, P., van de Beek, D., & van der Velde, N. (2018). Trazodone for Insomnia: A Systematic Review. *Drugs & Aging*, *35*(12), 1039-1051.
* Rissman, M., Kim, J. H., & O'Brien, S. (2020). Trazodone for sleep in older adults with dementia: a review. *Current Psychiatry Reports*, *22*(8), 40.
* Huang, A. R., Hwang, J., Mallet, L., Mamdani, M., & Rochon, P. A. (2020). Risk of serious adverse events in older adults using trazodone for sleep: A population-based cohort study. *Journal of the American Geriatrics Society*, *68*(1), 127-133.
* Maust, D. T., Kreyenbuhl, J., Stroup, T. S., & Blow, F. C. (2018). Adverse drug events associated with common psychotropic medications used in the elderly. *Journal of Clinical Psychiatry*, *79*(6), 17nr12015.
* Woolcott, J. C., Richardson, K. J., Wiens, M. O., Patel, A., Gerber, B., & Bergman, J. (2009). Falls and psychoactive medication use among older adults: a systematic review. *Archives of Internal Medicine*, *169*(21), 1987-1994.
Q.
Can antidepressants cause wait gain?
A.
Yes, some antidepressants can cause weight gain, but it varies depending on the medication and the person taking it. See below to understand more.
References:
Gill H, Gill B, El-Halabi S, Chen-Li D, Lipsitz O, Rosenblat JD, et al. (2020). Antidepressant Medications and Weight Change. Obesity (Silver Spring, Md.), 33022115.
https://pubmed.ncbi.nlm.nih.gov/33022115/
Fava M. (2000). Weight gain and antidepressants. The Journal of clinical psychiatry, 10926053.
https://pubmed.ncbi.nlm.nih.gov/10926053/
Mouawad M, Nabipur L, & Agrawal DK. (2025). Impact of Antidepressants on Weight Gain - PubMed - NIH. Archives of clinical and biomedical research, 40444017.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

“World’s Best Digital
Health Companies”
Newsweek 2024

“Best With AI”
Google Play Best of 2023

“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1